Literature DB >> 35463194

NATURAL LANGUAGE PROCESSING BASED MACHINE LEARNING MODEL USING CARDIAC MRI REPORTS TO IDENTIFY HYPERTROPHIC CARDIOMYOPATHY PATIENTS.

Divaakar Siva Baala Sundaram1, Shivaram P Arunachalam1, Devanshi N Damani1, Nasibeh Zanjirani Farahani1, Moein Enayati1, Kalyan S Pasupathy1, Adelaide M Arruda-Olson1.   

Abstract

Hypertrophic Cardiomyopathy (HCM) is the most common genetic heart disease in the US and is known to cause sudden death (SCD) in young adults. While significant advancements have been made in HCM diagnosis and management, there is a need to identify HCM cases from electronic health record (EHR) data to develop automated tools based on natural language processing guided machine learning (ML) models for accurate HCM case identification to improve management and reduce adverse outcomes of HCM patients. Cardiac Magnetic Resonance (CMR) Imaging, plays a significant role in HCM diagnosis and risk stratification. CMR reports, generated by clinician annotation, offer rich data in the form of cardiac measurements as well as narratives describing interpretation and phenotypic description. The purpose of this study is to develop an NLP-based interpretable model utilizing impressions extracted from CMR reports to automatically identify HCM patients. CMR reports of patients with suspected HCM diagnosis between the years 1995 to 2019 were used in this study. Patients were classified into three categories of yes HCM, no HCM and, possible HCM. A random forest (RF) model was developed to predict the performance of both CMR measurements and impression features to identify HCM patients. The RF model yielded an accuracy of 86% (608 features) and 85% (30 features). These results offer promise for accurate identification of HCM patients using CMR reports from EHR for efficient clinical management transforming health care delivery for these patients.

Entities:  

Keywords:  cardiac MRI; electronic health records (EHR); hypertrophic cardiomyopathy (HCM); machine learning; natural language processing (NLP)

Year:  2021        PMID: 35463194      PMCID: PMC9032778          DOI: 10.1115/dmd2021-1076

Source DB:  PubMed          Journal:  Proc 2021 Des Med Devices Conf DMD2021 (2021)


  16 in total

1.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

2.  Automated extraction of sudden cardiac death risk factors in hypertrophic cardiomyopathy patients by natural language processing.

Authors:  Sungrim Moon; Sijia Liu; Christopher G Scott; Sujith Samudrala; Mohamed M Abidian; Jeffrey B Geske; Peter A Noseworthy; Jane L Shellum; Rajeev Chaudhry; Steve R Ommen; Rick A Nishimura; Hongfang Liu; Adelaide M Arruda-Olson
Journal:  Int J Med Inform       Date:  2019-05-13       Impact factor: 4.046

Review 3.  Hypertrophic cardiomyopathy: a systematic review.

Authors:  Barry J Maron
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

Review 4.  Natural Language Processing in Radiology: A Systematic Review.

Authors:  Ewoud Pons; Loes M M Braun; M G Myriam Hunink; Jan A Kors
Journal:  Radiology       Date:  2016-05       Impact factor: 11.105

Review 5.  Mining electronic health records: towards better research applications and clinical care.

Authors:  Peter B Jensen; Lars J Jensen; Søren Brunak
Journal:  Nat Rev Genet       Date:  2012-05-02       Impact factor: 53.242

Review 6.  The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.

Authors:  Martin S Maron
Journal:  J Cardiovasc Transl Res       Date:  2009-11-07       Impact factor: 4.132

7.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

Authors:  Perry M Elliott; Aris Anastasakis; Michael A Borger; Martin Borggrefe; Franco Cecchi; Philippe Charron; Albert Alain Hagege; Antoine Lafont; Giuseppe Limongelli; Heiko Mahrholdt; William J McKenna; Jens Mogensen; Petros Nihoyannopoulos; Stefano Nistri; Petronella G Pieper; Burkert Pieske; Claudio Rapezzi; Frans H Rutten; Christoph Tillmanns; Hugh Watkins
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

Review 8.  Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: Current state of the art.

Authors:  Muhammad Umar Kamal; Irbaz Bin Riaz; Rajesh Janardhanan
Journal:  Cardiol J       Date:  2016-04-11       Impact factor: 2.737

9.  Identifying unmet clinical need in hypertrophic cardiomyopathy using national electronic health records.

Authors:  Mar Pujades-Rodriguez; Oliver P Guttmann; Arturo Gonzalez-Izquierdo; Bram Duyx; Constantinos O'Mahony; Perry Elliott; Harry Hemingway
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

10.  Defining genotype-phenotype relationships in patients with hypertrophic cardiomyopathy using cardiovascular magnetic resonance imaging.

Authors:  Robert J H Miller; Shahriar Heidary; Aleksandra Pavlovic; Audrey Schlachter; Rajesh Dash; Dominik Fleischmann; Euan A Ashley; Matthew T Wheeler; Phillip C Yang
Journal:  PLoS One       Date:  2019-06-14       Impact factor: 3.240

View more
  1 in total

1.  Natural language processing for identification of hypertrophic cardiomyopathy patients from cardiac magnetic resonance reports.

Authors:  Nakeya Dewaswala; David Chen; Huzefa Bhopalwala; Vinod C Kaggal; Sean P Murphy; J Martijn Bos; Jeffrey B Geske; Bernard J Gersh; Steve R Ommen; Philip A Araoz; Michael J Ackerman; Adelaide M Arruda-Olson
Journal:  BMC Med Inform Decis Mak       Date:  2022-10-18       Impact factor: 3.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.